USA. – A court in Missouri on Friday 20 November approved a class action settlement of up to $7.25 billion for people who claim that the herbicide Roundup caused the cancer with which they have been diagnosed. This cancer is known as non-Hodgkin lymphoma.
Bill Anderson, chief executive of Bayer, says the court's approval is an important step in the company's management of the Roundup litigation. According to Bayer, its subsidiary Monsanto will finance the settlement over a maximum of 21 years. The total includes payments that have already been made. The court order can be appealed, and Bayer says further payments will be suspended in such a case until the appeal process is concluded.
Sources: Bayer, Associated Press
This article is an automatic English translation of a Nuusflits article originally published in Afrikaans. Read the Afrikaans original.